Sabra Health Care REIT
SBRA · NASDAQ
About SBRA
- Employees
- 58
- Headquarters
- Tustin, Maryland
- Listed
- Nov 6, 2010
- Sector
- Real Estate
- Industry
- Health Care REITs
- Website
- sabrahealth.com
SBRA key statistics
- Market cap
- 4.96B
- Price-earnings ratio
- 73.38
- Dividend yield
- 6.04%
- Average volume
- 2.44M
- Volume
- 2.23M
- Open price
- $19.23
- High today
- $19.49
- Low today
- $19.17
- 52 Week high
- $22.77
- 52 Week low
- $17.17
Sabra Health Care REIT (SBRA) at a glance
As of Oct 20, 2026, Sabra Health Care REIT (SBRA) shares are priced at $19.42, giving the company a market cap of 4.96B, a price-to-earnings ratio of 73.38 and a dividend yield of 6.04%.
Today the stock has traded between $19.17 and $19.49. The current price is 1.3% above the day's low and 0.4% below its high.
Volume so far is 2.23M shares, in line with the average of 2.44M shares a day.
Over the past year Sabra Health Care REIT has ranged from $17.17 to $22.77, and now sits 40% of the way up that range.
Sabra Health Care REIT met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$0.10 per share against an estimate of $0.1763.
The average analyst price target is $23.26, 19.8% above the current price, from 12 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy33.3%
- Hold66.7%
- Sell0.0%
- Low
- $19.19
- Now
- $19.42
- High
- $26.25
SBRA earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 2 of the last 8 quarters, by 32.7% on average.
- Q3 FY24: reported $0.13 per share against an estimate of $0.1598
- Q4 FY24: reported $0.19 per share against an estimate of $0.1666
- Q1 FY25: reported $0.17 per share against an estimate of $0.1768
- Q2 FY25: reported $0.27 per share against an estimate of $0.1785
- Q3 FY25: reported $0.09 per share against an estimate of $0.1865
- Q4 FY25: reported $0.11 per share against an estimate of $0.1763
- Q1 FY26: reported $0.16 per share against an estimate of $0.169
- Q2 FY26: reported -$0.10 per share against an estimate of $0.1763
SBRA news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference
- Press releaseBusiness Wire
Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance
- Press releaseBusiness Wire
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report
- Press releaseBusiness Wire
Sabra Issues Business Update and Increases Full-Year 2026 Guidance
- Press releaseBusiness Wire
Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call
- Avi Kapoor
AbbVie, UnitedHealth, Sabra Health Care And A Consumer Defensive Stock On CNBC's 'Final Trades'
- Press releaseBusiness Wire
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in Nareit's REITweek 2026 Investor Conference
Similar companies
Companies in the same industry as Sabra Health Care REIT
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.